Latest News

Date Title Topic
27 Feb 2014 Combining HPV Status and Intratumour Heterogeneity for Predicting Outcome in Head and Neck Squamous Cell Carcinoma Patients Translational research - Head and neck cancers
26 Feb 2014 Panitumumab-Folfox4 Treatment and RAS Mutation in Colorectal Cancer Gastrointestinal cancers
26 Feb 2014 Selenium and Vitamin E Supplementation over Recommended Dietary Intake May Raise Prostate Cancer Risk Genitourinary cancers - Cancer prevention
25 Feb 2014 Promising Results of GOG Study with Bevacizumab for Advanced Cervical Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
24 Feb 2014 Bevacizumab Fails to Improve Overall Survival in First-Line Treatment for Glioblastoma Central nervous system malignancies - Anticancer agents & Biologic therapy
24 Feb 2014 2nd ESMO Consensus Conference on Lung Cancer – NSCLC
18 Feb 2014 ESMO E-Learning: First-line Therapy for Renal Cell Carcinoma: Defining New Standards of Care from Phase III Trials
17 Feb 2014 R-GCVP as First Line Treatment for DLBCL Patients with Cardiac Comorbidity Haematologic malignancies
17 Feb 2014 How to Reset Strategies to Maximise the Potential of PI3K/AKT/mTOR Inhibitors in Cancer Therapy Anticancer agents & Biologic therapy
14 Feb 2014 ESMO Interview: Franco Cavalli Comments on the Release of the World Cancer Report 2014 Bioethics, legal and economic issues
13 Feb 2014 FDA Approves Ibrutinib for Chronic Lymphocytic Leukaemia Haematologic malignancies - Anticancer agents & Biologic therapy
12 Feb 2014 Who are the Originators of Innovative Medicines in the EU? Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
11 Feb 2014 Rare Cancers: The Challenge of Accurate Diagnosis